Deep Track Capital, LP Viridian Therapeutics, Inc.\De Transaction History

Deep Track Capital, LP

$3.17 Billion
Q3 2025

A detailed history of Deep Track Capital, LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Deep Track Capital, LP holds 5,380,449 shares of VRDN stock, worth $155 Million. This represents 3.65% of its overall portfolio holdings.

Number of Shares

5,380,449

Previous 5,380,449 -0.0%

Holding current value

$155 Million

Previous $75.2 Million 53.86%

% of portfolio

3.65%

Previous 2.67%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$13.48 - $20.91 $11.6 Million - $17.9 Million	857,708 Added 18.96%	5,380,449 $72.5 Million
Q4 2024 Feb 14, 2025	BUY	$17.85 - $25.71 $13.8 Million - $19.8 Million	771,796 Added 20.58%	4,522,741 $86.7 Million
Q3 2024 Nov 14, 2024	SELL	$12.16 - $23.33 $2.1 Million - $4.03 Million	-172,904 Reduced 4.41%	3,750,945 $85.3 Million
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.26 $5.43 Million - $8.07 Million	467,796 Added 13.54%	3,923,849 $51 Million
Q1 2024 May 15, 2024	SELL	$17.09 - $23.82 $3 Million - $4.18 Million	-175,675 Reduced 4.84%	3,456,053 $60.5 Million
Q4 2023 Feb 14, 2024	BUY	$11.12 - $22.5 $7.43 Million - $15 Million	668,461 Added 22.56%	3,631,728 $79.1 Million
Q3 2023 Nov 14, 2023	BUY	$15.16 - $24.7 $25.5 Million - $41.6 Million	1,683,765 Added 131.6%	2,963,267 $45.5 Million
Q2 2023 Aug 14, 2023	BUY	$22.57 - $29.67 $1.11 Million - $1.46 Million	49,243 Added 4.0%	1,279,502 $30.4 Million
Q1 2023 May 15, 2023	SELL	$25.04 - $37.6 $13.5 Million - $20.3 Million	-540,895 Reduced 30.54%	1,230,259 $31.3 Million
Q4 2022 Feb 14, 2023	SELL	$18.78 - $29.74 $3.74 Million - $5.92 Million	-199,136 Reduced 10.11%	1,771,154 $51.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.7 - $25.5 $8.56 Million - $20.4 Million	800,000 Added 68.36%	1,970,290 $40.4 Million
Q1 2022 May 16, 2022	SELL	$16.79 - $20.88 $2.79 Million - $3.47 Million	-166,400 Reduced 12.45%	1,170,290 $21.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $21.5 $20.9 Million - $28.7 Million	1,336,690 New	1,336,690 $26.4 Million

Others Institutions Holding VRDN

# of Institutions

184

Shares Held

81.6M

Call Options Held

39.6K

Put Options Held

94.3K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $1.15B
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Account

Deep Track Capital, LP Viridian Therapeutics, Inc.\De Transaction History